% | $
Quotes you view appear here for quick access.

Incyte Corporation Message Board

  • beckyherbst_investorfan beckyherbst_investorfan Jan 9, 2014 10:35 AM Flag

    INCY Been On Fire! What Do You All Know About ICPT???

    I wonder if any of you have followed that Company. ICPT? The stock today is OUT OF CONTROL. Is the science, and these results they just announced, ground-breaking?....

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Seeking Alpha just published an update--I don't know enough to judge how good it is, but it's abundant: (I hope the link survived).

      Important caveats are that this was a focused therapeutic phase 2 with a laboratory finding as endpoint, and that there are other drugs addressing the problem in various phases of development, not necessarily trailing. The author strongly suspects that NASH is a problem that will take more than one drug to solve.

    • Hard to judge. Non-alcoholic steatohepatitis as a drug target looks like something on the same general order as hepatitis C. Big enough, but a lot of physicians / patients might choose not to treat it at all. But the possible linkage with metabolic syndrome and thus type 2 diabetes has almost unlimited possibilities. The drug looks excellent.

      • 1 Reply to jacosa
      • I missed this one completely.....never ever got on my radar. Never even heard of it until a few days ago. I think I need to work harder. Been slacking off for over a year ago. I need to be taken out and flogged for that.....meaning never ever getting it on my radar! Seriously, I need to work harder....after this summer...once INCY PV results are clear and more info is out on IDO and PanCa registrational/sub group analysis. Although I agree with you on PV market size vs commercialization questions. A bit of a different ball game for the INCY sales and Marketing team. I would feel better if overall market went through a 10-15 percent correction. That would be time to also sift for relative strength.......among the biotechs.

    • Becky, you were right on ICPT, it was by no means pricey at $280... what was I thinking??

    • Seems a little pricey at 280$ a share. Maybe look at it on a dip.

112.46-8.37(-6.93%)Oct 6 4:00 PMEDT